{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:22:51Z","timestamp":1787239371365,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/eye.2015.289","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T05:31:03Z","timestamp":1455255063000},"page":"333-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Involution patterns of retinopathy of prematurity after treatment with intravitreal bevacizumab: implications for follow-up"],"prefix":"10.1038","volume":"30","author":[{"given":"M","family":"Isaac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Mireskandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"issue":"12","key":"BFeye2015289_CR1","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.1167\/iovs.08-2584","volume":"49","author":"LE Smith","year":"2008","unstructured":"Smith LE . Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture. Invest Ophthalmol Vis Sci 2008; 49 (12): 5177\u20135182.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"BFeye2015289_CR2","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ . Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011; 364 (7): 603\u2013615.","journal-title":"N Engl J Med"},{"issue":"3 Suppl","key":"BFeye2015289_CR3","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1097\/IAE.0b013e3181644ad2","volume":"28","author":"GA Lalwani","year":"2008","unstructured":"Lalwani GA, Berrocal AM, Murray TG, Buch M, Cardone S, Hess D et al. Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity. Retina 2008; 28 (3 Suppl): S13\u2013S18.","journal-title":"Retina"},{"issue":"6","key":"BFeye2015289_CR4","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","volume":"28","author":"HA Mintz-Hittner","year":"2008","unstructured":"Mintz-Hittner HA, Kuffel RR Jr . Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina 2008; 28 (6): 831\u2013838.","journal-title":"Retina"},{"issue":"3","key":"BFeye2015289_CR5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3928\/15428877-20070501-09","volume":"38","author":"A Travassos","year":"2007","unstructured":"Travassos A, Teixeira S, Ferreira P, Regadas I, Travassos AS, Esperancinha FE et al. Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging 2007; 38 (3): 233\u2013237.","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"8","key":"BFeye2015289_CR6","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/archophthalmol.2012.592","volume":"130","author":"J Hu","year":"2012","unstructured":"Hu J, Blair MP, Shapiro MJ, Lichtenstein SJ, Galasso JM, Kapur R . Reactivation of retinopathy of prematurity after bevacizumab injection. Arch Ophthalmol 2012; 130 (8): 1000\u20131006.","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"BFeye2015289_CR7","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.ophtha.2011.04.028","volume":"118","author":"DM Moshfeghi","year":"2011","unstructured":"Moshfeghi DM, Berrocal AM . Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice. Ophthalmology 2011; 118 (7): 1227\u20131228.","journal-title":"Ophthalmology"},{"issue":"5","key":"BFeye2015289_CR8","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1167\/iovs.13-13744","volume":"55","author":"YQ Ni","year":"2014","unstructured":"Ni YQ, Huang X, Xue K, Yu J, Ruan L, Shan HD et al. Natural involution of acute retinopathy of prematurity not requiring treatment: factors associated with the time course of involution. Invest Ophthalmol Vis Sci 2014; 55 (5): 3165\u20133170.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"BFeye2015289_CR9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3928\/0191-3913-19940501-09","volume":"31","author":"MW Preslan","year":"1994","unstructured":"Preslan MW, Butler J . Regression pattern in retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 1994; 31 (3): 172\u2013176.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"5","key":"BFeye2015289_CR10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1001\/archopht.118.5.645","volume":"118","author":"MX Repka","year":"2000","unstructured":"Repka MX, Palmer EA, Tung B . Involution of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 2000; 118 (5): 645\u2013649.","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"BFeye2015289_CR11","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.ophtha.2004.02.005","volume":"111","author":"DK Coats","year":"2004","unstructured":"Coats DK, Miller AM, Brady McCreery KM, Holz ER, Paysse EA . Involution of threshold retinopathy of prematurity after diode laser photocoagulation. Ophthalmology 2004; 111 (10): 1894\u20131898.","journal-title":"Ophthalmology"},{"key":"BFeye2015289_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jcjo.2015.10.004","volume":"50","author":"K Mireskandari","year":"2015","unstructured":"Mireskandari K, Collins ME, Tehrani N . Intravitreal bevacizumab for retinopathy of prematurity: Considerations for informed consent. Can J Ophthalmol 2015; 50: 409\u2013412.","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"BFeye2015289_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jaapos.2015.01.009","volume":"19","author":"M Isaac","year":"2015","unstructured":"Isaac M, Mireskandari K, Tehrani N . Treatment of type 1 retinopathy of prematurity with bevacizumab versus laser. J AAPOS 2015; 19 (2): 140\u2013144.","journal-title":"J AAPOS"},{"issue":"3","key":"BFeye2015289_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jaapos.2013.01.004","volume":"17","author":"S Ittiara","year":"2013","unstructured":"Ittiara S, Blair MP, Shapiro MJ, Lichtenstein SJ . Exudative retinopathy and detachment: a late reactivation of retinopathy of prematurity after intravitreal bevacizumab. J AAPOS 2013; 17 (3): 323\u2013325.","journal-title":"J AAPOS"},{"issue":"12","key":"BFeye2015289_CR15","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","volume":"121","author":"Early Treatment For Retinopathy Of Prematurity Cooperative G","year":"2003","unstructured":"Early Treatment For Retinopathy Of Prematurity Cooperative G. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003; 121 (12): 1684\u20131694.","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"BFeye2015289_CR16","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/pch\/15.10.667","volume":"15","author":"A Jefferies","year":"2010","unstructured":"Jefferies A . Retinopathy of prematurity: Recommendations for screening. Paediatr Child Health 2010; 15 (10): 667\u2013674.","journal-title":"Paediatr Child Health"},{"issue":"1","key":"BFeye2015289_CR17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ajo.2012.06.010","volume":"155","author":"WC Wu","year":"2013","unstructured":"Wu WC, Kuo HK, Yeh PT, Yang CM, Lai CC, Chen SN . An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in taiwan. Am J Ophthalmol 2013; 155 (1): 150\u20138 e1.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2015289_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1542\/peds.2012-2996","volume":"131","author":"American Academy of Pediatrics, American Academy of Ophthalmology","year":"2012","unstructured":"American Academy of Pediatrics, American Academy of Ophthalmology American Association for Pediatric Ophthalmology and Strabismus American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2012; 131: 189\u2013195.","journal-title":"Pediatrics"},{"issue":"1","key":"BFeye2015289_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jaapos.2009.10.011","volume":"14","author":"JC Law","year":"2010","unstructured":"Law JC, Recchia FM, Morrison DG, Donahue SP, Estes RL . Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity. J AAPOS 2010; 14 (1): 6\u201310.","journal-title":"J AAPOS"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2015289.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2015289","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2015289.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:26:38Z","timestamp":1684416398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2015289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFeye2015289"],"URL":"https:\/\/doi.org\/10.1038\/eye.2015.289","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,12]]},"assertion":[{"value":"16 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}